GO TO CMA Home
GO TO Inside CMA
GO TO Advocacy and Communications
GO TO Member Services
GO TO Publications
GO TO Professional Development
GO TO Clinical Resources

GO TO What's New
GO TO Contact CMA
GO TO Web Site Search
GO TO Web Site Map



Canadian Medical Association Journal
March 24'98

MDs sceptical, but patients say bee venom relieves MS symptoms

CMAJ 1998;158:708

© 1998 Canadian Medical Association


Every Saturday, 40 people make their way to Ron Lofthouse's beehives in Buckhorn, Ont. They're looking to get stung, not buy honey, but they're not participating in some bizarre S and M ritual. Instead, they maintain, honey bee venom (HBV) not only offers relief from the pain but also returns the mobility that has been lost over the years to a relentless foe, multiple sclerosis (MS).

Whitby, Ont., family physician Scott Henderson has been monitoring one of his patients, who has been diagnosed with MS and is a member of the group of 40. He has been treating the patient since 1992 and prescribing medication to treat the disease, but until recently he had been frustrated and was simply charting the progress of the disease as it robbed his patient of more and more functions.

Bee venom

Henderson's patient decided on her own to try HBV; she was stung for the first time last April and since then Henderson has monitored results of the weekly stings she receives. He has noticed some improvement in both her physical condition and attitude, and says the amount of medication she is taking has been reduced. The woman says she has regained her energy. Last year, for the first time in years, she went raspberry picking.

However, despite such anecdotal evidence an expert in the MS field is sceptical and prescribes caution. Neurologist Paul O'Connor, director the MS clinic at St. Michael's Hospital in Toronto, will neither prescribe nor recommend bee venom to his patients. He said its benefits are unproven and there is a risk of allergic reaction to the stings, which increases with the number of times a person is stung.

Henderson agrees that caution is warranted, and says he cannot say for sure whether the improvement in his patient is due to natural remission, which is a characteristic of this form of the disease, or the HBV. Firmer evidence is expected later this year, when a study dealing with the impact of HBV on MS is expected to be published. — © Peter Wilton

Comments Send a letter to the editor responding to this article
Envoyez une lettre à la rédaction au sujet de cet article